1-3-dimethylthiourea and Ocular-Hypertension

1-3-dimethylthiourea has been researched along with Ocular-Hypertension* in 1 studies

Other Studies

1 other study(ies) available for 1-3-dimethylthiourea and Ocular-Hypertension

ArticleYear
Comparison of intraocular treatment of DMTU and SOD following retinal ischemia in rats.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1999, Volume: 15, Issue:6

    The effect of intravitreal injections of DMTU (dimethylthiourea) and SOD (superoxide dismutase), two free radical scavengers, was evaluated in a rat model of retinal ischemia induced by elevated intraocular pressure. The drugs were administered just before or just after a 60 min ischemia. At days 2 and 7 after reperfusion, retinal recovery was evaluated by electroretinography. At day 7, layer thicknesses and cell rows were measured from histologic sections of paraffin-embedded retinas. In the vehicle-treated control group, we observed a decrease in the inner retinal layers and b-wave amplitude impairment. SOD injection (6 units/eye) protected the retina from ischemia/reperfusion injury. At day 2 after reperfusion, electroretinographic recovery was more efficient when SOD was administered just after ischemia (99%) than after pretreatment with SOD (81%) (p<0.03). In the DMTU-treated group (75 microg/eye), only the pretreatment induced significant electrophysiologic (40%) (p<0.001) and morphologic recovery.

    Topics: Administration, Topical; Animals; Electroretinography; Free Radical Scavengers; Ischemia; Male; Ocular Hypertension; Rats; Rats, Wistar; Reperfusion Injury; Retina; Retinal Diseases; Superoxide Dismutase; Thiourea; Time Factors

1999